IL6 and neoplasm: Indeed, at the bone metastatic site, IL-6 indirectly contributes to OC differentiation and activation by increasing RANKL expression in OB via the JAK/STAT-3 signaling pathway (Palmqvist et al., 2002), thereby further promoting tumor local aggressiveness.